For the Quarter Ending December 2025
Ofloxacin Prices in APAC
- In China, the Ofloxacin Price Index fell quarter-over-quarter in Q4 2025, driven by decreasing production costs and subdued consumer demand.
- Ofloxacin production costs declined in December 2025, as producer prices decreased by 1.9% year-over-year.
- Weak consumer demand was evident with CPI at 0.8% and retail sales up 0.9% year-over-year in December 2025.
- Demand for Ofloxacin API was supported by robust pharmaceutical market growth in 2025 and expanding industrial output.
- The manufacturing index expanded in December 2025, and industrial production increased by 5.2% year-over-year.
- Elevated inventory levels for basic chemicals were projected in 2025 due to global overcapacity.
- China's medicine exports steadily increased during the first eleven months of 2025, supporting trade flows.
- Unemployment stood at 5.1% in December 2025, contributing to cautious consumer sentiment.
Why did the price of Ofloxacin change in December 2025 in APAC?
- Producer prices declined by 1.9% year-over-year in December 2025, lowering Ofloxacin manufacturing costs.
- Subdued consumer demand, with CPI at 0.8% and retail sales up 0.9% year-over-year in December 2025.
- Intensified global overcapacity in key chemical building blocks in 2025 pressured Ofloxacin prices downward.
Ofloxacin Prices in North America
- In United States, the Ofloxacin Price Index rose in Q4 2025, driven by elevated production costs and robust health spending.
- Ofloxacin production costs increased during Q4 2025, influenced by a 3.0% rise in PPI year-over-year in November 2025.
- Elevated natural gas spot prices in Q4 2025 and increased electricity costs in November 2025 raised Ofloxacin manufacturing expenses.
- Ofloxacin demand outlook remained strong in 2025, supported by robust national health spending growth.
- A 4.4% unemployment rate in December 2025 bolstered patient access to Ofloxacin and healthcare services.
- Industrial production increased 2.0% year-over-year in December 2025, supporting the broader Ofloxacin supply chain.
- Consumer confidence at 89.1 in December 2025 indicated moderate optimism, indirectly supporting stable Ofloxacin demand.
- U.S. chemical feedstock export capacity expanded in Q4 2025, influencing broader chemical market dynamics.
Why did the price of Ofloxacin change in December 2025 in North America?
- Ofloxacin production costs increased from a 2.7% CPI rise in December 2025 and elevated natural gas prices.
- Robust national health spending in 2025 and a 4.4% unemployment rate in December 2025 supported Ofloxacin demand.
- Increased electricity costs in November 2025 and a 3.0% PPI rise in November 2025 pressured Ofloxacin prices.
Ofloxacin Prices in Europe
- In Germany, the Ofloxacin Price Index declined in Q4 2025, due to intensified competitive pressure in October 2025.
- Ofloxacin production costs rose from high raw material costs in October 2025 and strengthened electricity prices in December 2025.
- The Manufacturing Index was contracting in December 2025, indicating a slowdown in overall economic activity.
- Ofloxacin demand outlook was challenged by a 6.2% unemployment rate and low consumer confidence (-17.5 index) in December 2025.
- Weak domestic and export orders in October 2025 impacted German chemical industry trade flows.
- German chemical industry capacity utilization remained low in 2025, as order backlogs plummeted in October 2025.
- European natural gas prices faced upward pressure into winter 2025, increasing Ofloxacin energy feedstock costs.
- The Producer Price Index (PPI) declined 2.5% year-over-year in December 2025, easing some input cost pressures.
Why did the price of Ofloxacin change in December 2025 in Europe?
- Intensified competitive pressure from international markets in October 2025 prompted chemical companies to lower prices.
- Weak domestic and export orders in October 2025 and a contracting Manufacturing Index in December 2025 reduced demand.
- Despite a 1.8% CPI increase in December 2025, a 2.5% PPI decline in December 2025 eased producer costs.
For the Quarter Ending September 2025
Ofloxacin Prices in North America
- In United States, Ofloxacin Price Index rose in Q3 2025, driven by rising costs and strong pharmaceutical market sentiment.
- Ofloxacin production costs increased in Q3 2025, influenced by 2.6% PPI rise by August 2025.
- Rising input prices and strengthened industrial electricity in September 2025 elevated Ofloxacin expenses.
- Ofloxacin demand was positive, supported by strengthened pharmaceutical market sentiment and surging drug approvals in Q3 2025.
- Robust consumer spending, retail sales up 5.42% in September 2025, supported patient access and Ofloxacin demand.
- Low unemployment rate of 4.3% in September 2025 contributed to stable healthcare spending and Ofloxacin demand.
- US manufacturing inventories tightened in Q3 2025, and chemical output slipped, impacting Ofloxacin supply.
- Henry Hub natural gas prices inched up from August to September 2025, increasing Ofloxacin energy costs.
- Declining consumer confidence to 94.2 in September 2025 may temper future Ofloxacin demand.
Why did the price of Ofloxacin change in September 2025 in North America?
- Ofloxacin production costs rose from 2.6% PPI increase by August 2025.
- Strong pharmaceutical sentiment and 5.42% retail sales growth in September 2025 boosted demand.
- Tightened US manufacturing inventories and decelerated output growth in Q3 2025 pressured prices.
Ofloxacin Prices in APAC
- In China, Ofloxacin Price Index fell in Q3 2025, influenced by falling factory-gate prices and subdued consumer confidence.
- Ofloxacin production costs increased in Q3 2025 due to rising natural gas prices and higher demand for chemical intermediates.
- Ofloxacin demand outlook was mixed; retail sales grew 3.0% in September 2025, but consumer confidence was low.
- China's industrial production expanded 6.5% year-on-year in September 2025, supporting stable supply of Ofloxacin inputs.
- The Manufacturing Index was contracting in September 2025, reflecting a slowdown in the broader chemical industry.
- Deflationary pressures, with CPI falling 0.3% year-on-year in September 2025, impacted consumer purchasing power.
- Pharmaceutical goods exports from China inched down August-September 2025, while imports saw a more significant decline.
- Ofloxacin price forecast suggests continued pressure from weak domestic demand and persistent chemical oversupply.
Why did the price of Ofloxacin change in September 2025 in APAC?
- Producer prices fell 2.3% in September 2025, pressuring Ofloxacin selling prices downward.
- Consumer confidence at 89.6 in September 2025 reflected pessimism, moderating Ofloxacin demand.
- Rising natural gas prices in Q3 2025 contributed to increased production costs for Ofloxacin intermediates.
Ofloxacin Prices in Europe
- In Germany, the Ofloxacin Price Index rose quarter-over-quarter in Q3 2025, driven by increased production costs.
- Ofloxacin production costs increased in Q3 2025, influenced by elevated energy prices for German businesses.
- Demand for Ofloxacin faced headwinds in Q3 2025 as Germany's Manufacturing Index was contracting in September 2025.
- A low 3.9% unemployment rate in September 2025 supported Ofloxacin demand by bolstering consumer purchasing power.
- Overall industrial output declined by -1.0% year-over-year in September 2025, indicating a weaker economic environment.
- Consumer confidence remained significantly negative at -23.6 in September 2025, impacting discretionary healthcare spending.
- German chemical exports faced weak demand in Q3 2025, while European sales stagnated, affecting Ofloxacin trade.
- The pharmaceutical market in Germany experienced moderate growth in 2025, driven by an aging population and chronic diseases.
Why did the price of Ofloxacin change in September 2025 in Europe?
- Elevated energy costs in Q3 2025 increased Ofloxacin production expenses in Germany.
- German pharmaceutical industry faced increased price and cost pressure during Q3 2025.
- Producer prices declined by -1.7% in September 2025, moderating Ofloxacin input cost increases.
For the Quarter Ending June 2023
North America
Across the North American region, the prices of Ofloxacin demonstrate a mixed price trajectory throughout the second quarter of 2023. At the beginning of the second quarter, the prices continued to follow the market trend of the previous month resulting in a steady rising inquiry from the domestic pharmaceutical and healthcare sector.
However, in May, ofloxacin prices went down by 2 percent from the previous month. The combination of decreased demand, increased supply, and a weakening currency has led to a decline in Ofloxacin prices in the USA this month. In recent months, both countries, China and India, being the major supplier of Pharmaceutical API, including Ofloxacin, have increased production to meet the growing demand, resulting in higher stocks.
Also, the weakening of the US dollar against other currencies supported this month’s decreased trade as this has made Ofloxacin more expensive for buyers in the US, which has reduced demand and put further downward pressure on prices. However, the prices rebounded again in June but steadily. Also, the domestic Ofloxacin suppliers have a sizable supply on hand that allows them to meet local demand. Moreover, the US Consumer Price Index (CPI) rose by 0.1% in June 2023 from May. With this, the prices for Ofloxacin get settled at USD 41650/MT CFR Los Angeles.
Asia Pacific
During the second quarter, the price of Ofloxacin, an Active Pharmaceutical Ingredient, demonstrated a zigzag market sentiment throughout the second quarter of 2023, as at the beginning of April. The price surged moderately, followed by the market sentiments of the previous month. Consumption remained consistent in April in both the domestic and global markets. Furthermore, export activities from China stayed on the upper side because of a persistent inquiry from the international market. Moreover, towards the middle of the second quarter, the prices began to drop and decreased by around 4 percent. This price decrease was supported by ample inventories among the merchants, followed by reduced export momentum. Also, the strengthening of the Chinese Yuan against the US dollar in recent months has made various end-products, including Ofloxacin, more expensive for buyers in other countries, owing to which the traders and manufacturers reduced their prices even more, to balance out their market outlook. Following this, the market improved for pharmaceutical API with the termination of Q2-2023. According to market experts, China’s Consumer Price Index (CPI) rose by 0.2% in June 2023 from May, but manufacturing remained weak. With this, Ofloxacin API prices across the region market were settled at USD 4810/MT FOB Shanghai.
Europe
For the whole second quarter, the prices of Ofloxacin depict a parallel market trend as that of the United States. The prices continued upward until April while dropping significantly in May and rebounding stably in June. April’s price trend was supported by consistent demand balanced with continuous manufacturing activities and supplies among the merchants. While as May 2023 approached, the prices went down by more than 5 percent and settled at USD 24500/MT. This price trend was attributed to a drop in international inquiries and changes in climatic conditions that resulted in lessened orders sentiments from retailers and suppliers, as hotter climatic might degrade the medicines and their raw material. Also, this month’s prices were further supported by the weakened German Purchasing Manager Index (PMI) for Germany, which was 52.2, down from 54.8 in May. Moving towards the end of Q2, the prices for Ofloxacin were assembled at USD 46650/MT CFR Hamburg, demonstrating a stable incremented trend with participants ensuring enough stocks to meet overall demand.
For the Quarter Ending March 2023
North America
With a significant increase in domestic demand and constrained supply among market players, the price of Ofloxacin rose during the first quarter of 2023. In early January 2023, Ofloxacin inventories among market participants were sufficient to meet all needs, as opposed to December 2022. By the middle of the first quarter, a slowdown in trade activity and a steady increase in demand forced traders and suppliers to raise their quotes, further supporting the upward price trend for Ofloxacin. Overall, the cost of Ofloxacin in the United States was constructed at USD 47640/MT CFR Los Angeles.
Asia Pacific
Prices for Ofloxacin increased throughout the first quarter of 2023 in the APAC area as a result of heightened demand following the Lunar New Year and the government abandoning its zero-COVID policy. Both consumption and output notably surged during the holiday-shortened month of January in China. The producers were forced to increase production and stock their shelves with downstream of Ofloxacin before the end of the quarter. Moreover, ease in trade activity along with a decrease in freight charges, further supported the upsurged market trend of Ofloxacin in the APAC region. With this, prices increased at a modest rate and reached USD 46680/MT FOB Shanghai.
Europe
The first quarter of 2023 saw a strong upward pricing trend for Ofloxacin as queries from the downstream sector substantially increased. Furthermore, as 2023 approaches, commerce between Germany and China climbed to a record level despite political worries about over-dependence, becoming China Germany's top trading partner for the seventh consecutive year. Early in January, a balance between supply and demand was seen in the local market, but as February drew closer, the price went on the higher side consistently, which helped the market participants to raise their prices of Ofloxacin. Additionally, increased trade activity and persistent inquiries from exporting nations strengthened the Ofloxacin market value through the end of March 2023. With this, the prices for Ofloxacin settled at USD 48800/ MT CFR Hamburg.
